Vlahos Alexander E, Call Connor C, Kadaba Samarth E, Guo Siqi, Gao Xiaojing J
Department of Chemical Engineering, Stanford University, Stanford, CA, 94305, USA.
The Chinese Undergraduate Visiting Research (UGVR) Program, Stanford, CA, 94305, USA.
bioRxiv. 2023 Oct 4:2023.10.04.560774. doi: 10.1101/2023.10.04.560774.
Synthetic biology currently holds immense potential to engineer the spatiotemporal control of intercellular signals for biomedicine. Programming behaviors using protein-based circuits has advantages over traditional gene circuits such as compact delivery and direct interactions with signaling proteins. Previously, we described a generalizable platform called RELEASE to enable the control of intercellular signaling through the proteolytic removal of ER-retention motifs compatible with pre-existing protease-based circuits. However, these tools lacked the ability to reliably program complex expression profiles and required numerous proteases, limiting delivery options. Here, we harness the recruitment and antagonistic behavior of endogenous 14-3-3 proteins to create RELEASE-NOT to turn off protein secretion in response to protease activity. By combining RELEASE and RELEASE-NOT, we establish a suite of protein-level processing and output modules called Compact RELEASE (compRELEASE). This innovation enables functions such as logic processing and analog signal filtering using a single input protease. Furthermore, we demonstrate the compactness of the post-translational design by using polycistronic single transcripts to engineer cells to control protein secretion via lentiviral integration and leverage mRNA delivery to selectively express cell surface proteins only in engineered cells harboring inducible proteases. CompRELEASE enables complex control of protein secretion and enhances the potential of synthetic protein circuits for therapeutic applications, while minimizing the overall genetic payload.
合成生物学目前在设计用于生物医学的细胞间信号的时空控制方面具有巨大潜力。使用基于蛋白质的电路来编程细胞行为比传统基因电路具有优势,例如递送简便以及与信号蛋白直接相互作用。此前,我们描述了一个名为RELEASE的通用平台,通过蛋白水解去除与预先存在的基于蛋白酶的电路兼容的内质网保留基序,从而实现对细胞间信号传导的控制。然而,这些工具缺乏可靠地编程复杂表达谱的能力,并且需要多种蛋白酶,限制了递送选择。在此,我们利用内源性14-3-3蛋白的招募和拮抗行为来创建RELEASE-NOT,以响应蛋白酶活性关闭蛋白质分泌。通过结合RELEASE和RELEASE-NOT,我们建立了一套称为紧凑型RELEASE(compRELEASE)的蛋白质水平加工和输出模块。这一创新使得能够使用单一输入蛋白酶实现诸如逻辑处理和模拟信号滤波等功能。此外,我们通过使用多顺反子单转录本,通过慢病毒整合对细胞进行工程改造以控制蛋白质分泌,并利用mRNA递送仅在含有可诱导蛋白酶的工程细胞中选择性表达细胞表面蛋白,从而证明了翻译后设计的紧凑性。CompRELEASE能够对蛋白质分泌进行复杂控制,并增强合成蛋白质电路在治疗应用中的潜力,同时将整体基因负载降至最低。